Literature DB >> 9542647

Massive culture of human liver cancer cells in a newly developed radial flow bioreactor system: ultrafine structure of functionally enhanced hepatocarcinoma cell lines.

M Kawada1, S Nagamori, H Aizaki, K Fukaya, M Niiya, T Matsuura, H Sujino, S Hasumura, H Yashida, S Mizutani, H Ikenaga.   

Abstract

With a view to initiating clinical trials, cell morphology and function for a newly developed artificial liver support system employing highly functional human liver cell line, FLC-7, cultured in a radial flow bioreactor were compared to cells grown in a conventional monolayer culture. The radial flow bioreactor consists of a vertically extended cylindrical matrix comprised of porous glass bead microcarriers through which liquid medium flows from the periphery in toward the central axis generating a beneficial concentration gradient of oxygen and nutrients, while preventing excessive shear stresses or buildup of waste products. The three-dimensional culture system supports high-density (1.1 x 10(8) cells/ml-matrix), large scale cultures (4.4 x 10(10) cells/400 ml-bioreactor) with long-term viability. Scanning and transmission electron microscopy (SEM and TEM) revealed that cells cultured in a monolayer system were flattened and extended with numerous cytoplasmic projections. Cells in the three-dimensional culture were spherical and covered with microvillilike processes resembling liver cells in vivo. The cells were solidly attached on the surfaces and within the pores of the microcarriers in highly dense colonies. The spherical cells remained in close contact with adjacent cells, while circulation of liquid medium flowed freely through spaces between cells. FLC-7 cells produced albumin at a rate of 6.41 micrograms/24 h/10(6) cells. Alpha-fetoprotein (AFP) production dropped nearly threefold in comparison to monolayer cultures. Results demonstrated that the new artificial liver support systems (ALSS) provides a superior three-dimensional culture environment that allows cells to perform at naturally functioning levels.

Entities:  

Mesh:

Year:  1998        PMID: 9542647     DOI: 10.1007/s11626-998-0092-z

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  18 in total

1.  [Establishment and characterization of a human hepatocellular carcinoma cell line JHH-7 producing alpha -fetoprotein and carcinoembryonic antigen--changes in secretion of AFP and CEA from JHH-7 cells after heat treatment].

Authors:  S Homma; S Nagamori; K Fujise; S Hasumura; H Sujino; T Matsuura; K Shimizu; M Niiya; H Kameda
Journal:  Hum Cell       Date:  1990-06       Impact factor: 4.174

2.  Demonstration of biochemical function by extracorporeal xenohepatocytes in an anhepatic animal model.

Authors:  S L Nyberg; W D Payne; B Amiot; K Shirabe; R P Remmel; W S Hu; F B Cerra
Journal:  Transplant Proc       Date:  1993-04       Impact factor: 1.066

3.  Hepatocyte aggregate culture technique for bioreactors in hybrid liver support systems.

Authors:  J C Gerlach; K Klöppel; C Müller; N Schnoy; M D Smith; P Neuhaus
Journal:  Int J Artif Organs       Date:  1993-12       Impact factor: 1.595

4.  Development of a serum-free and heat-sterilizable medium and continuous high-density cell culture.

Authors:  Y Minamoto; K Ogawa; H Abe; Y Iochi; K Mitsugi
Journal:  Cytotechnology       Date:  1991-01       Impact factor: 2.058

5.  The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation.

Authors:  F Greif; O L Bronsther; D H Van Thiel; A Casavilla; S Iwatsuki; A Tzakis; S Todo; J J Fung; T E Starzl
Journal:  Ann Surg       Date:  1994-01       Impact factor: 12.969

6.  Control of cerebral oedema by total hepatectomy and extracorporeal liver support in fulminant hepatic failure.

Authors:  J Rozga; L Podesta; E LePage; A Hoffman; E Morsiani; L Sher; G M Woolf; L Makowka; A A Demetriou
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

7.  Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions.

Authors:  S L Nyberg; K Shirabe; M V Peshwa; T D Sielaff; P L Crotty; H J Mann; R P Remmel; W D Payne; W S Hu; F B Cerra
Journal:  Cell Transplant       Date:  1993 Nov-Dec       Impact factor: 4.064

8.  Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver.

Authors:  S L Nyberg; R P Remmel; H J Mann; M V Peshwa; W S Hu; F B Cerra
Journal:  Ann Surg       Date:  1994-07       Impact factor: 12.969

9.  A case of syncytial giant-cell hepatitis treated with an extracorporeal liver assist device.

Authors:  N L Sussman; M J Finegold; J P Barish; J H Kelly
Journal:  Am J Gastroenterol       Date:  1994-07       Impact factor: 10.864

10.  A stable long-term hepatocyte culture system for studies of physiologic processes: cytokine stimulation of the acute phase response in rat and human hepatocytes.

Authors:  A Bader; I H Borel Rinkes; E I Closs; C M Ryan; M Toner; J M Cunningham; R G Tompkins; M L Yarmush
Journal:  Biotechnol Prog       Date:  1992 May-Jun
View more
  10 in total

Review 1.  Molecular biology of hepatitis C virus.

Authors:  Tetsuro Suzuki; Hideki Aizaki; Kyoko Murakami; Ikuo Shoji; Takaji Wakita
Journal:  J Gastroenterol       Date:  2007-06-29       Impact factor: 7.527

Review 2.  Bioreactors for 3-dimensional high-density culture of human cells.

Authors:  Tomokazu Matsuura
Journal:  Hum Cell       Date:  2006-02       Impact factor: 4.174

3.  Reconstruction of liver organoid using a bioreactor.

Authors:  Masaya Saito; Tomokazu Matsuura; Takahiro Masaki; Haruka Maehashi; Keiko Shimizu; Yoshiaki Hataba; Tohru Iwahori; Tetsuro Suzuki; Filip Braet
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

4.  The effectiveness of a novel cartridge-based bioreactor design in supporting liver cells.

Authors:  Mei Niu; Paul Hammond; Robin N Coger
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

Review 5.  Is there a future for liver-assist devices?

Authors:  P Rosenthal
Journal:  Curr Gastroenterol Rep       Date:  2000-02

6.  Establishment of a human hepatocyte line (OUMS-29) having CYP 1A1 and 1A2 activities from fetal liver tissue by transfection of SV40 LT.

Authors:  K Fukaya; S Asahi; S Nagamori; M Sakaguchi; C Gao; M Miyazaki; M Namba
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-05       Impact factor: 2.416

7.  p38 Mitogen-activated protein kinase regulates nuclear receptor CAR that activates the CYP2B6 gene.

Authors:  Kosuke Saito; Rick Moore; Masahiko Negishi
Journal:  Drug Metab Dispos       Date:  2013-03-28       Impact factor: 3.922

Review 8.  Three-dimensional cell culture models for investigating human viruses.

Authors:  Bing He; Guomin Chen; Yi Zeng
Journal:  Virol Sin       Date:  2016-10-27       Impact factor: 4.327

Review 9.  Three-Dimensional Cell Culture Systems for Studying Hepatitis C Virus.

Authors:  Chui-Wa So; Glenn Randall
Journal:  Viruses       Date:  2021-01-30       Impact factor: 5.048

Review 10.  Physiologically relevant microsystems to study viral infection in the human liver.

Authors:  Dennis McDuffie; David Barr; Ashutosh Agarwal; Emmanuel Thomas
Journal:  Front Microbiol       Date:  2022-09-28       Impact factor: 6.064

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.